Skip to main content

Published locations for Addition of quizartinib to LDAC improves outcomes in older patients with FLT3-ITD-mutated AML

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Addition of quizartinib to LDAC improves outcomes in older patients with FLT3-ITD-mutated AML

User login

  • Reset your password
  • /content/addition-quizartinib-ldac-improves-outcomes-older-patients-flt3-itd-mutated-aml
  • /hematology-oncology/article/247819/aml/addition-quizartinib-ldac-improves-outcomes-older-patients